Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
基本信息
- 批准号:10488446
- 负责人:
- 金额:$ 33.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-12 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAdherenceAntibioticsAtopobium vaginaeBacterial VaginosisBiological Response Modifier TherapyCD4 Positive T LymphocytesCellsCommunitiesDataDevelopmentEducationFemaleGenitalGenitaliaHIVHIV riskHealthHigh Risk WomanHumanInfectionInflammationInterventionLactobacillusMethodsMicrobeMucous MembranePhasePopulationPreventionRecurrenceRiskSexually Transmitted DiseasesSouth AfricaSouth AfricanSyndromeTechnologyTestingVaginaWomancohortcytokinedysbiosismicrobial communitymicrobiotapeerplacebo controlled studyrandomized placebo controlled trialreproductive tractself-renewalstandard carevaginal lactobacillivaginal microbiotayoung woman
项目摘要
ABSTRACT
The human vaginal microbiota has long been considered a factor impacting women’s risk for acquiring sexually
transmitted infections (STIs) including HIV, but the extent of this contribution and the underlying mechanisms
have not been well defined. The FRESH (Females Rising through Education, Support, and Health) cohort
consists of HIV-uninfected young South African women in a region where over 60% of 24 year old women are
HIV infected. In this population, we demonstrated that women with vaginal microbial communities dominated by
Lactobacillus crispatus had a 4-fold lower rate of HIV acquisition, reduced numbers of mucosal CD4+ T cells and
lower levels of genital tract proinflammatory cytokines compared with women with communities deficient in
Lactobacillus species. This common syndrome of vaginal dysbiosis, characterized by a diverse, non-
Lactobacillus dominant microbial community, is known as bacterial vaginosis (BV). Standard treatment with
antibiotics leads to a decrease in BV-associated microbes, but re-colonization with Lactobacillus species is often
slow, and recurrence of BV is common. Given the apparent protection from infections afforded by a Lactobacillus-
dominant vaginal microbiota, an intervention strategy using live biotherapeutic products (LBP) is a logical
approach. LACTIN-V, vaginally administered and containining the endogenous L. crispatus CTV-05 strain, has
shown excellent tolerability and close to 80% colonization in Phase 1 and 2a studies in the US. We propose a
Phase 2 randomized, placebo-controlled trial of LACTIN-V nested within the FRESH cohort. In 60 young South
African women with a non-Lactobacillus-dominant microbiota, we plan to assess whether this intervention a)
reduces proinflammatory cytokines and HIV target cells in the lower genital tract, b) leads to a persistent
Lactobacillus-dominant vaginal microbial community and c) is safe and acceptable in this population of young
women at high risk for HIV. The development of female-controlled HIV prevention methods is an urgent priority,
but significant challenges remain, such as adherence issues with current approaches and the need for
sustainable large scale distribution. The use of a safe LBP is an important paradigm shift in the development of
HIV prevention technologies. The FRESH / LACTIN-V project will provide critical data to assess if LACTIN-V
could have the potential to offer women a safe, effective, durable, self-renewing, coitally independent, multi-
purpose prevention product that promotes vaginal health and provides protection from HIV and potentially other
STIs.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG R COHEN其他文献
CRAIG R COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG R COHEN', 18)}}的其他基金
University of California Launching Future Leaders in Global Health Research Training Program
加州大学推出全球健康研究未来领导者培训计划
- 批准号:
10879589 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
University of California Launching Future Leaders in Global Health Research Training Program
加州大学推出全球健康研究未来领导者培训计划
- 批准号:
10881124 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
- 批准号:
10406532 - 财政年份:2021
- 资助金额:
$ 33.13万 - 项目类别:
University of California Global Health Institute Program for Fellows and Scholars
加州大学全球健康研究所研究员和学者计划
- 批准号:
10253430 - 财政年份:2021
- 资助金额:
$ 33.13万 - 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
- 批准号:
10372975 - 财政年份:2019
- 资助金额:
$ 33.13万 - 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
- 批准号:
10617632 - 财政年份:2019
- 资助金额:
$ 33.13万 - 项目类别:
Uwezo: Developing an Office of Sponsored Research in KEMRI with HIV Research Training
Uwezo:通过艾滋病毒研究培训在 KEMRI 中建立一个赞助研究办公室
- 批准号:
9277256 - 财政年份:2016
- 资助金额:
$ 33.13万 - 项目类别:
Agricultural intervention for food security and HIV healthoutcomes in Kenya
肯尼亚粮食安全和艾滋病毒健康结果的农业干预
- 批准号:
9064868 - 财政年份:2015
- 资助金额:
$ 33.13万 - 项目类别:
Agricultural intervention for food security and HIV healthoutcomes in Kenya
肯尼亚粮食安全和艾滋病毒健康结果的农业干预
- 批准号:
8922460 - 财政年份:2015
- 资助金额:
$ 33.13万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 33.13万 - 项目类别:
Fellowship Programs